← Browse by Condition
Medical Condition
chronic rhinosinusitis with nasal polyps
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 2
ClinicalMetric tracks all active clinical trials for chronic rhinosinusitis with nasal polyps sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — chronic rhinosinusitis with nasal polyps Clinical Trials
How many clinical trials are currently recruiting for chronic rhinosinusitis with nasal polyps?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for chronic rhinosinusitis with nasal polyps, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic rhinosinusitis with nasal polyps?
chronic rhinosinusitis with nasal polyps research spans Phase 2 (1 trial), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic rhinosinusitis with nasal polyps clinical trial?
Eligibility criteria for chronic rhinosinusitis with nasal polyps trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 4 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04869436 Phase 4
Recruiting
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
Enrollment
27 pts
Location
Canada
Sponsor
London Health Sciences Centre ...
NCT06914908 Phase 2
Recruiting
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study
Enrollment
64 pts
Location
United States, Argen...
Sponsor
Sanofi
NCT07187583 Phase 4
Recruiting
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Enrollment
135 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
NCT05902325 Phase 4
Recruiting
Identifying Predictors Of Response To Mepolizumab In CRSwNP
Enrollment
36 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology